WALTERS GROUP Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
1
Insider Buys Sum
$7.75M
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of WALTERS GROUP

According to the SEC Form 4 filings, WALTERS GROUP, being in a position of

  1. 10 percent owner at Zentalis Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 10794973 shares for $22.92M, and sold 0 shares,
    over all time since 2025-12-31, has bought 10794973 shares for $22.92M, and sold 0 shares.

Biography of WALTERS GROUP

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $22,924,4682100
Sells
 $000

Comparison of Insiders on Amount of Buys and Sells

2026-08-14PurchaseZentalis Pharmaceuticals, Inc.
ZNTL
10 percent owner
4.33M
6.0656%
$3.50$15.17M-22.05%
2025-12-31PurchaseZentalis Pharmaceuticals, Inc.
ZNTL
10 percent owner
6.46M
8.0671%
$1.20$7.75M+162.22%
Total: 2
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.